FR2207715A1 - (Leu3 leu4)-arginine and lysine-vasopressins - natriuretics with low hypertensive activity useful for treatment of oedema - Google Patents

(Leu3 leu4)-arginine and lysine-vasopressins - natriuretics with low hypertensive activity useful for treatment of oedema

Info

Publication number
FR2207715A1
FR2207715A1 FR7341563A FR7341563A FR2207715A1 FR 2207715 A1 FR2207715 A1 FR 2207715A1 FR 7341563 A FR7341563 A FR 7341563A FR 7341563 A FR7341563 A FR 7341563A FR 2207715 A1 FR2207715 A1 FR 2207715A1
Authority
FR
France
Prior art keywords
natriuretics
vasopressins
leu4
leu3
oedema
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7341563A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2207715A1 publication Critical patent/FR2207715A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The novel polypeptides are of formula (I): (where Q is Arg or Lys, and Y is Cys, beta-mercaptopropionyl or Gly-Cys), all the amino-acids being in the 1-configuration, together with their non-toxic, therapeutically useful acid addn. salts. They may be prepd. by several methods, e.g. oxidn. and removal of the protectings gps. of a peptide of formula (II): (where R5 and r6 are H or sulphydryl protecting gps., and R7 is H, NH2 or Gly-NH). Many peptide inters. in the prepn. of (I) are also novel.
FR7341563A 1972-11-24 1973-11-22 (Leu3 leu4)-arginine and lysine-vasopressins - natriuretics with low hypertensive activity useful for treatment of oedema Withdrawn FR2207715A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1718472 1972-11-24

Publications (1)

Publication Number Publication Date
FR2207715A1 true FR2207715A1 (en) 1974-06-21

Family

ID=4423420

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7341563A Withdrawn FR2207715A1 (en) 1972-11-24 1973-11-22 (Leu3 leu4)-arginine and lysine-vasopressins - natriuretics with low hypertensive activity useful for treatment of oedema

Country Status (7)

Country Link
JP (1) JPS4982682A (en)
AU (1) AU6147073A (en)
BE (1) BE807704A (en)
DE (1) DE2357334A1 (en)
FR (1) FR2207715A1 (en)
NL (1) NL7314486A (en)
ZA (1) ZA737898B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151016A2 (en) * 1984-01-26 1985-08-07 Medical College of Ohio Arginine vasopressin antagonists
EP0189326A2 (en) * 1985-01-23 1986-07-30 Medical College of Ohio Derivatives of arginine vasopressin antagonists

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492421B1 (en) 1997-07-31 2002-12-10 Athena Neurosciences, Inc. Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
US6489300B1 (en) 1997-07-31 2002-12-03 Eugene D. Thorsett Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
US7030114B1 (en) 1997-07-31 2006-04-18 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
NZ502582A (en) * 1997-07-31 2002-07-26 American Home Prod Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
US6583139B1 (en) 1997-07-31 2003-06-24 Eugene D. Thorsett Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6362341B1 (en) 1997-07-31 2002-03-26 Athena Neurosciences, Inc. Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4
US6939855B2 (en) 1997-07-31 2005-09-06 Elan Pharmaceuticals, Inc. Anti-inflammatory compositions and method
US6291453B1 (en) 1997-07-31 2001-09-18 Athena Neurosciences, Inc. 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
US6559127B1 (en) 1997-07-31 2003-05-06 Athena Neurosciences, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6423688B1 (en) 1997-07-31 2002-07-23 Athena Neurosciences, Inc. Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4
US6407066B1 (en) 1999-01-26 2002-06-18 Elan Pharmaceuticals, Inc. Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151016A2 (en) * 1984-01-26 1985-08-07 Medical College of Ohio Arginine vasopressin antagonists
EP0151016A3 (en) * 1984-01-26 1987-04-01 Medical College of Ohio Arginine vasopressin antagonists
EP0189326A2 (en) * 1985-01-23 1986-07-30 Medical College of Ohio Derivatives of arginine vasopressin antagonists
EP0189326A3 (en) * 1985-01-23 1988-10-26 Medical College of Ohio Derivatives of arginine vasopressin antagonists

Also Published As

Publication number Publication date
NL7314486A (en) 1974-05-28
AU6147073A (en) 1975-04-17
ZA737898B (en) 1974-07-31
JPS4982682A (en) 1974-08-08
DE2357334A1 (en) 1974-06-06
BE807704A (en) 1974-05-24

Similar Documents

Publication Publication Date Title
FR2207715A1 (en) (Leu3 leu4)-arginine and lysine-vasopressins - natriuretics with low hypertensive activity useful for treatment of oedema
ES420458A1 (en) Novel heptapeptides having gastrin activity
BR8008818A (en) PHARMACOLOGICALLY ACTIVE PEPTIDES AND MEDICINES CONTAINING THE SAME
ES403973A1 (en) (ile3,leu4)-vasopressin analogs and intermediates
GB1509745A (en) Pharmaceutically active polypeptides
IL38546A0 (en) A process for the preparation of new complexes of biologically active peptides,polypeptides,proteins or derivatives or salts thereof having prolonged and/or increased activity
ES421854A1 (en) Lysino-calcium chloride and pharmaceutically acceptable acid salts thereof
FR2052569A5 (en) Cysteine-contg peptides
ES417951A1 (en) Peptides of ACTH activity containing {60 -aminooxy carboxylic acid on the N-terminal moiety, and a process for the preparation thereof
GB1409993A (en) Antitussive
GB1388227A (en) Amino-acid salts of sulphoglycopeptides
GB1111563A (en) Methods for preparing n-benzyl-n',n"-dimethylguanidine
GB1044144A (en) Process for the manufacture of a polypeptide
ES430202A1 (en) N-(furyl-or thienyl-methyl)-Desoxy-normorphines and -norcodeines and salt thereof
GB562349A (en) Improvements relating to the manufacture of sulphanilamide derivatives
FR2200001A1 (en) Polypeptide analogues of arginine- and lysine-vasopressin - having natriuretic activity, and novel peptide intermediates
CA1019740A (en) "amino propanediol" derivatives, preparation process and therapeutic applications to humans
GB935282A (en) Improvements in and relating to sulphonyl ureas and their manufacture
GB1214576A (en) Complexes having a prolonged adrenocorticotropic activity and process for their manufacture
GB1389859A (en) Salts of fluorinated amino acid with optically active acids or bases
IT1053811B (en) PROCEDURE FOR THE PRODUCTION OF PURIFIED CARBON DIOXIDE SUITABLE IN PARTICULAR FOR THE SYNTHESIS OF UREA
GB1471371A (en) Cyclopenteno-b-pyridine derivative
ES363792A1 (en) 2-Sulfanilamido-3-Halogeno-Pyridines
GB1046167A (en) Novel amine salts
BE769091A (en) Raubasine nicotinate - vasodilator

Legal Events

Date Code Title Description
ST Notification of lapse